[Lab] QYB orfo — Medutest came back 99.2% against a claimed 99.0%
QYB orfo — Medutest came back 99.2% against a claimed 99.0%. One vial, one service, one member paying, which is the only kind of result this board should treat as evidence. 99.2% and 99.0% — those are the numbers, and they are the ones I am willing to defend. Oral semaglutide is a peptide co-formulated with an…
Left up. It is careful about what is peptide and what is not, which is more than most threads here manage.
oral semaglutide is a peptide with an absorption enhancer, this is not that
Push back: daily dosing is not automatically better adherence. It is a different failure mode, not a solved problem.
Milligram-for-milligram comparison with an injectable peptide is not meaningful and I should not have made it.
daily dosing changes adherence in both directions
Disagree. You are comparing doses across a small molecule and a peptide, which is not a comparison of anything.
[deleted]
Is that from the publication or the press release?
Agreed — non-peptide is the fact that everything else follows from, including the manufacturing and the analytics.